Advances in cancer stem cell targeting: How to strike the evil at its root

Area of Science:

• Oncology
• Cancer Biology
• Therapeutics

Background:

• Metastatic cancer remains a significant clinical challenge, with unmet needs in effective anti-metastatic therapies.
• Cancer stem cells (CSCs) are implicated in tumor initiation, metastasis, and therapeutic resistance, highlighting them as critical therapeutic targets.

Purpose of the Study:

• To review current and emerging therapeutic strategies targeting cancer stem cells (CSCs) for managing metastatic cancer.
• To explore novel drug delivery systems for enhancing the efficacy of anti-CSC therapies.

Main Methods:

• Review of recent scientific literature on CSC-targeted therapies.
• Analysis of therapeutic agents including antibody derivatives, nucleic therapeutics, small molecules, and genetic payloads.
• Evaluation of viral and non-viral vector technologies for targeted drug delivery.

Main Results:

• Targeted therapies are being developed to address CSC-specific internal and membrane markers.
• Advanced delivery systems, including viral and non-viral vectors, show promise for precise therapeutic agent transport.
• Significant progress has been made, but challenges in effectively combating CSCs persist.

Conclusions:

• Targeting CSCs represents a promising avenue for developing novel anti-metastatic therapies.
• Innovations in drug development and delivery systems are essential for overcoming CSC-mediated cancer progression.
• Further research is needed to address remaining challenges and translate these strategies into clinical practice.